Synthesis and action of the cyclic AMP antagonist, prostaglandylinositol cyclic phosphate (Cyclic PIP), in Dictyostelium discoideum

Biological Chemistry

Volumn 379, Issue 6, 1998, Pages 727-730

  Kaiser, Anna Maria ^a   Wasner, Heinrich K ^a   Spindler, Klaus Dieter ^b  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Activated inositol phosphate; Cyclic AMP antagonist; Cyclic PIP; Dictyostelium discoideum; Prostaglandins

Indexed keywords

INOSITOL PHOSPHATE; PROSTAGLANDIN DERIVATIVE;

ADSORPTION CHROMATOGRAPHY; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; DICTYOSTELIUM DISCOIDEUM; GEL FILTRATION CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYCLIC AMP; DICTYOSTELIUM; INOSITOL PHOSPHATES; PROSTAGLANDINS E; RATS;

DICTYOSTELIUM DISCOIDEUM;

EID: 0031814642     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bloom, L., and Kay, R.R. (1988). The search for morphogens in Dictyostelium. Bioessays 9, 187-191.
2. Europe-Firmer, G.N., and Newell, P.C. (1985). Inositol 1,4,5-trisphosphate induces cyclic GMP formation in Dictyostelium discoideum. Biochem. Biophys. Res. Commun. 130, 1115-1122.
3. 3H]-inositol into inositol polyphosphates during development of Dictyostelium. Biochem. Biophys. Res. Commun. 181, 191-196.
4. Gerisch, G. (1987). Cyclic AMP and other signals controlling cell development and differentiation in Dictyostelium. Annu. Rev. Biochem. 56, 853-879.
5. Gerisch, G., and Hess, B. (1974). Cyclic AMP-controlled oscillations in suspended Dictyostelium cells: Their relation to morphogenetic cell interactions. Proc. Natl. Acad. Sci. USA 71, 2118-2122.
6. Gypakis, A., and Wasner, H.K. (1997). Biosynthesis of activated inositol phosphate, a novel class of inositol phosphates (abstract). Exp. Clin. Endocrinol. 104, A18.
7. Kaiser, A.M., and Wasner, H.K. (1993). Synthesis and action of the endogenous cyclic AMP antagonist, prostaglandylinositol cyclic phosphate, in Dictyostelium discoideum (abstract IV 21). Biol. Chem. Hoppe Seyler 374, 723.
8. Konijn, T.M., and van Haastert, P.J.M. (1987). Measurement of chemotaxis in Dictyostelium. Meth. Cell. Biol. 28, 283-298.
9. Krill, D.C., and Town, C.D. (1988). Arachidonate-dependent oxygen consumption in Dictyostelium discoideum. J. Gen. Microbiol. 134, 2123-2129.
10. Nellen, W., Silan, C., and Firtel, R.A. (1984). DNA-mediated transformation in Dictyostelium discoideum: regulated expression of an actin gene fusion. Mol. Cell. Biol. 4, 2890-2898.
11. Parent, C.A., and Devreotes, P.N. (1996). Molecular genetics of signal transduction in Dictyostelium. Annu. Rev. Biochem. 65, 411-440.
12. Roos, W., Nanjundiah, V., Malchow, D., and Gerisch, G. (1975). Amplification of cyclic AMP signals in aggregating cells of Dictyostelium discoideum. FEBS Lett. 53, 139-142.
13. Salge, U. (1987). Untersuchungen zur biologischen Synthese des cAMP-Antagonisten. Thesis, Heinrich-Heine-Universität, Düsseldorf.
14. Stephens, L.R., Kay, R.R., and Irvine, R.F. (1980). A myo-inositol D-3 hydroxykinase activity in Dictyostelium. Biochem. J. 272, 201-210.
15. Theibert, A., and Devreotes, P.N. (1984). Adenosine and its derivatives inhibit the cyclic AMP signaling response in Dictyostelium discoideum. Dev. Biol. 106, 166-173.
16. Town, C.D., Krill, D.C., and Hassid, A.I. (1985). Inhibition of differentiation in Dictyostelium discoideum by anti-inflammatory drugs. Development, Growth and Differentiation 27, 111-116.
17. Wang, M., van Haastert, P.J.M., and Schaap, P. (1986). Multiple effects of differentiation-inducing factor on prespore differentiation and cyclic AMP signal transduction in Dictyostelium. Differentiation 33, 24-28.
18. Wasner, H.K. (1975). Regulation of protein kinase and phosphoprotein phosphatase by cyclic AMP and cyclic AMP antagonist. FEBS Lett. 57, 60-63.
19. Wasner, H.K. (1981). Biosynthesis of cyclic AMP antagonist in hepatocytes from rats after adrenalin-or insulin-stimulation (isolation, purification and prostaglandin E requirement for its synthesis). FEBS Lett. 133, 260-264.
20. Wasner, H.K., Lemoine, H., Junger, E., Leßmann, M., and Kaufmann, R. (1991). Prostaglandylinositol cyclic phosphate, a new second messenger. In: Prostaglandins, Leukotrienes, Lipoxins and PAF. J.M. Bailey, ed. (New York, Plenum Press), pp. 153-168.
21. Wasner, H.K., Kaufmann, R., and Lemoine, H. (1992). Mass spectrometric identification of prostaglandylinositol, the dephosphorylated cyclic AMP antagonist, cyclic PIP. Analusis 20, 171-177.
22. Wasner, H.K., Salge, U., and Gebel, M. (1993). The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone stimulated synthesis and identification as prostaglandylinositol cyclic phosphate. Acta Diabetol. 30, 220-232.
23. Wasner, H.K., Weber, S., Partke, H.J., and Amini-Hadi-Kiashar, H. (1994). Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol. 31, 175-182.
24. Wasner, H.K., Leßmann, M., Conrad, M., Amini, H., Psarakis, E., and Mir-Mohammad-Sadegh, A. (1996). Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes. Acta Diabetol. 33, 126-138.
25. Wasner, H.K., Salge, U., Psarakis, E., and Niktopoulos, A. (1997). Insulin resistance, a result of reduced synthesis of cyclic PIP, a mediator of insulin action? Regulation of cyclic PIP synthetase activity by oral antidiabetic and antihypertenseive drugs. Acta Diabetol. 34, 257-264.
26. Weeks, G. (1976). The manipulation of the fatty acid composition of Dictyostelium discoideum and its effect on cell differentiation. Biochim. Biophys. Acta 450, 21-32.
27. 2+-dependent secretion. J. Biol. Chem. 267, 8396-8403.